⌘K
Loading ticker…
As of 2026-08-24, Geron Corp (GERN) has a 3-month relative strength percentile of 79 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.1%, relative volume 1.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
GERN is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $8M.
Held by 41 ETFs · $118M across latest filings · largest weight 1.81% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| SBIO | 0.51% | $825K | −0.18 pp |
| ESML | 0.03% | $779K | −0.03 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.04% |
| $637K |
| −0.02 pp |
| ISMD | 0.14% | $456K | −0.09 pp |
| ONEQ | 0.00% | $436K | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $396K | — |
| QQQS | 0.30% | $57K | −0.37 pp |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GERN Jan avg: 2.11% median: -4.50% win: 50% σ: 24.77% n: 4 2022-04-12 → 2026-07-31 | GERN Feb avg: -5.78% median: -3.53% win: 50% σ: 27.07% n: 4 2022-04-12 → 2026-07-31 | GERN Mar avg: 5.52% median: -10.48% win: 25% σ: 40.02% n: 4 2022-04-12 → 2026-07-31 | GERN Apr avg: 4.48% median: 3.36% win: 60% σ: 12.11% n: 5 2022-04-12 → 2026-07-31 | GERN May avg: 2.02% median: -2.13% win: 40% σ: 19.86% n: 5 2022-04-12 → 2026-07-31 | GERN Jun avg: 5.02% median: 2.40% win: 60% σ: 10.78% n: 5 2022-04-12 → 2026-07-31 | GERN Jul avg: 3.53% median: 0.94% win: 80% σ: 15.23% n: 5 2022-04-12 → 2026-07-31 | GERN Aug avg: 8.97% median: 10.97% win: 75% σ: 27.64% n: 4 2022-04-12 → 2026-07-31 (current) | GERN Sep avg: -7.67% median: -7.89% win: 0% σ: 5.18% n: 4 2022-04-12 → 2026-07-31 | GERN Oct avg: -8.25% median: -8.75% win: 0% σ: 2.30% n: 4 2022-04-12 → 2026-07-31 | GERN Nov avg: -0.01% median: 0.91% win: 75% σ: 4.59% n: 4 2022-04-12 → 2026-07-31 | GERN Dec avg: 2.86% median: 6.82% win: 75% σ: 11.72% n: 4 2022-04-12 → 2026-07-31 |